In consultation: Guidance and quality standards
Showing 1 to 13 of 13
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Domestic Abuse | Draft scope consultation | NICE guideline | |
| Filgotinib for treating axial spondyloarthritis ID6594 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over ID6542 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Guidance on the use of electroconvulsive therapy | Review proposal consultation | Technology appraisal guidance | |
| Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people 1 year and over ID6400 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Pharmalgen for the treatment of bee and wasp venom allergy | Review proposal consultation | Technology appraisal guidance | |
| Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma | Review proposal consultation | Technology appraisal guidance | |
| Port Delivery platform with ranibizumab for treating wet age-related macular degeneration [ID3983] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Middle meningeal artery embolisation for chronic subdural haematomas | Draft scope consultation | Interventional procedures guidance | |
| Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver | Draft scope consultation | Interventional procedures guidance | |
| In-situ normothermic regional perfusion of the abdomen for donor livers following circulatory death | Draft scope consultation | Interventional procedures guidance | |
| Tarlatamab for treating small-cell lung cancer that has progressed after platinum-based chemotherapy ID6617 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442] | Draft guidance | Technology appraisal guidance |